ASDs Flashcards

(79 cards)

1
Q

List the voltage gated Na+ Channel Blockers

A
Phenytoin, Fosphenytoin
Carbamazepine, Oxcarbazepine
Valproic Acid
Lamotrigine
Topiramate
Zonisamide
Lacosamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which state is are the Na+ channels blocked during

A

Inactivated state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phenytoin (Dilantin)

Indication

A

Focal seizures

Generalized tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phenytoin (Dilantin)

PK

A

Non-linear

  • With change in dose, t1/2 changes
  • Induces metabolic enzymes, different time to steady state based on dose

t 1/2 15-20 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phenytoin (Dilantin)

Metabolism

A

CYP2C9/19

Forms: Arene Oxide Active metabolite with ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phenytoin ADRs

A
Nystagmus
Diplopia
Sedation
Gingival Hyperplasia** 
Hirsutism**

Long term:
Choreoathetosis, peripheral neuropathy

Severe:
Toxic epidermal necrolysis
SJS

**Common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phenytoin (Dilantin)

Teratogenicity

A

Fetal Hydantoin Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phenytoin (Dilantin)

DDIs

A

-High Plasma Protein Binding (Displacement issues)
-CYP2C9/19 inhibitors
(Cimetidine, Isoniazid, Sulfonamides, Valproic Acid)
-CYP2C9/19 Inducers
(Barbiturates, ChronicEtOH, Carbamazepine, Rifampin)
-Drugs that decrease absorption (Antacids)

-Phenytoin induces CYP3A4, CYP2C, CYP2D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carbamazepine (Tegretol, Carbatrol)

MOA

A

Na+ channel blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phenytoin (Dilantin)

MOA

A

Voltage dependent Na+ channel blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Carbamazepine (Tegretol, Carbatrol)

PK: t1/2 and metabolism

A

t 1/2: 12-30 h (~15 for long term)

Metabolized by CYP3A4 (auto induction), CYP2C9/19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carbamazepine (Tegretol, Carbatrol)

Indication

A
  • All seizure types except absence seizures

- Temperal lobe epilepsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carbamazepine (Tegretol, Carbatrol)
ADRs

BBW, Dose Related, Dose Unrelated, and Long-term Use

A

BBW: Leukopenia

Dose related: 
Fatigue, sedation
Nystagmus
Dilopia
Nausea
Ataxia

Dose Unrelated:
Rash & SJS
Teratogenicity

Longterm:
Seizure freq. increased
Aplastic anemia
Hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carbamazepine (Tegretol, Carbatrol)

DDIs

A

-Strong CYP3A4 inducer
Other ASDs, Oral Contraceptives, Warfarin, Corticosteroids.

-CYP3A4 inhibitors
Valproate, Cimetidine, Erythromycin

-CYP3A4 inducers
Phenytoin, Carbamazepine, primidone, phenobarbital, Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oxcarbazepine (Trileptal)

MOA and Indication

A

Same as Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Oxcarbazepine (Trileptal)
PK
t1/2
t1/2 metabolites
Elimination
A

Oxcarbazepine : 1-2 h
Active metabolites : 8-12 h

Glucuronide (Urinary)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oxcarbazepine (Trileptal)
ADRs
Dose related
Dose un-related

A

Less common, less severe

Dose related: Somnolence, dilopia, ataxia

Dose-unrelated: Rash, hyponatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oxcarbazepine (Trileptal)

DDIs

A

WeakCYP3A4 induction:

Less affected by CYP3A4 modulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Valproic Acid (Depakote, Depakene)
MOAs (3)
A
  • Na channel blocker
  • Stimulates GABA synthesis
  • Inhibits GABA transaminase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
Valproic Acid (Depakote, Depakene)
Indication
A

Most seizure types INCLUDING absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lamotrigine (Lamictal)

MOA

A

Na+ Channel Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lamotrigine (Lamictal)

Indication

A

All seizure types

Generalized seizures in children with absence attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Lamotrigine (Lamictal)
PK
t1/2
Elimination

A

25 h

Glucuronide conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Lamotrigine (Lamictal)

ADRs

A

Headache, nausea, vomiting

Rash (SJS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Lamotrigine (Lamictal) | DDIs
Hepatic inducers increase glucuronidation (Clearance)
26
Topiramate (Topamax) | MOAs (3)
- Na+ blocker - Augments GABA at GABAaR - Blockatde of Glutamate receptors (Kainate, AMPA)
27
Topiramate (Topamax) | Indications
Focal Seizures | Generalized tonic-clonic seizures
28
Topiramate (Topamax) PK t1/2
20-30 h
29
Topiramate (Topamax) | ADRs
Sedation, cognitive slowing, confusion | Fetal malformations
30
Topiramate (Topamax) | DDIs
Carbamazepine, Phenytoin increase topiramate metabolism
31
Zonisamide (Zonegran) | MOAs (2)
Na+ channel blocker | T-type Ca2+ channel blocker
32
Zonisamide (Zonegran) | Indication
Focal Seizures
33
Zonisamide (Zonegran) PK t1/2 metabolism
>60 h | Partially by CYP3A4
34
Zonisamide (Zonegran) | ADRs
Dizzienes, ataxia Somnolence/Insomnia Cognitive problems Rash (fatal)
35
Zonisamide (Zonegran) | DDIs
-Phenytoin, Carbamazepine (CYP3A4 inducers) Valproic Acid, Cimetidine, Erythromycin (CYP3A4 inhibitors) Sufonamide hypersensitivity (contraindicated)
36
Lacosamide (Vimpat) | MOA
Enhances slow inactivation of Na+ channels
37
Lacosamide (vimpat) | Indication
Adjunctive therapy for focal-onset seizures
38
Lacosamide (Vimpat) PK t1/2 metabolism
12-16 h | CYP2C19
39
Lacosamide (Vimpat) | DDIs
N/a? CYP2C19 Inducers? Phenytoin and Carbamazepine?
40
Gabapentin (Neurontin, Gralise) | MOAs(2)
Ca2+ Channel Blocker --> Decrease glutamate release GABAergic --> Increases release of GABA
41
Gabapentin (Neurontin, Gralise) | Indication
Focal Seizures
42
``` Gabapentin (Neurontin, Gralise) PK t1/2 PPB Metabolism ```
~6 h 0% hardly metabolized
43
Gabapentin (Neurontin, Gralise) | ADRs
Sedation, Somnolence, Dizziness, Fatigue Nystagmus Ataxia
44
Gabapentin (Neurontin, Gralise) | DDIs
None (Based on PK)
45
Pregabalin (Lyica) | MOA
Ca++ channel blocker --> decreased Glu release
46
Pregabalin (Lyrica) | Indication
Focal seizures
47
``` Pregabalin (Lyrica) PK t1/2 PPB Metabolism ```
~6 h 0% hardly metabolized
48
Pregabalin (Lyrica)
``` SEDATION, somnolence, dizziness Headache WEIGHT GAIN Dry mouth Blurred vision ```
49
Pregabalin (Lyrica) | DDIs
N/a
50
Tiagabine (Gabitril) | MOA
GABA reuptake inhibitor
51
Tiagabine (Gabitril) | Indication
``` Focal seizures (Mainly Ad on, no longer 1st line) ```
52
Tiagabine (Gabitril) PK t1/2 metabolism
7h | CYP3A
53
Tiagabine (Gabitril) | ADRs
Sedation, dizzines, somnolence Difficulty with concentration abdominal Pain **Can actually induce status epilepticus!! (rare)
54
Tiagabine (Gabitril) | DDIs
CYP3A inducers/inhibitors
55
Vigabatrin (Sabril) | MOA
GABA Transaminase Inhibitor Transaminase converts GABA to glutamate (in the synaptic cleft) which then is converted to glutamine in the glia to be recycled to glutamate in glutaminergic neurons
56
Vigabatrin (Sabril) | Indication
Adjunct for infantile spasms, Frefractory complex focal seizures, West Syndrome
57
``` Vigabatriin (Sabril) PK t1/2 PPB Elimination ```
5-7 h 0% Renal
58
Vigabatrin (Sabril) | ADRs
Sedation, fatigue - Depresion, psychotic disurbances - WHITE MATTTER LESIONS (30%) - PROGRESSIVE PERMANENT BILATERAL VISION LOSS (30-50%!!!!!) --> Only available through "SHARE"
59
Vigabatrin (Sabril) | DDIs
Decreases phenytoinn Cp by 20-30% Minimal due to PK
60
Phenobarbital (Luminal) | MOA
GABAa Receptor agonist
61
Phenobarbital (Luminal) | Indication
All seizure types except absence seizures
62
``` Phenobarbital (Luminal) PK t1/2 PPB Elimination ```
>60 h 40-60% Renal excretion of non-metabolized drug *Strong induction of CYP2C and CYP3A (DDIs)
63
Phenobarbital (Luminal) | ADRs
Sedation, tolerance develops Nystagmus, Ataxia Learning Difficulties (Don't give to children)
64
Phenobarbital (Luminal) | DDIs
Induces CYP2C and CYP3A, induces metabolism of other drugs
65
Benzodiazepines | Drugs
Diazepam (Valium, Diastat) Clonazepam (Klonopin) Lorazepam (Ativan) Clobazam (Onfi)
66
Benzodiazepines | MOA
GABAa Receptor
67
Benzodiazepines | Indications (Drugs specific)
``` Diazepam - Status Epilepticus Clonazepam - Long-term (also absence) Lorazepam - Status Epilepticus Clorazepate - Long term Clobazam Lennox-Gastaut Syndrome (Adjunct) ```
68
Benzodiazepines PK t1/2 PPB
20-50 h | 85-99%
69
Benzodiazepines | ADRs
Tolerance (50%, 1-6 months)!! CNS depression, STRONG Sedation, Lethargy Aggressiveness (25%) Withdrawal Syndrom
70
Benzodiazepines | DDIs
GABAa Acting substances
71
ASDs for for focal seizures and generalized tonic-clonic seizures
Carbamazepine Phenytoin Valproic Acid Phenobarbital Lamotrigine, Oxcarbazepine, Felbamate, Gabapentin, Pregabalin, Vigabatrin, Lacosamide, Levitiracetam, Tiagabine, Topiramate
72
ASDs for Gernalized absence, myclonic, or atonic seizures
Valproic Acid Ethosuximide Clonazepam Lamotrigene
73
ASDs for status epilepticus
Diazepam | Lorazepam
74
ASDs with weight gain
``` Valproate (common) Carbamazepine Gabapentin Pregabalin Perampanel ```
75
ASDs with weight los
Topiramate Felbamate Zonisamide
76
ASDs that are weight neutral
Phenytoin Lamotrigine Lacosamide Levetiraetam
77
Hormonal contraception DDIs | CYP3A4
``` Carbamazepine Oxcarbazepine Felbamate Topiramate Phenytoin Phenobarbital ```
78
ASDs with Teratogenic effects
Phenytoin Phenobarbital Valproic Acid Carbamazepine
79
Which ASD probably transfers to breast milk
Levetiracetam